• Fe3O4@ZIF-8 Nanoparticles for Combating Jaw Osteomyelitis

  2026-05-15

  This study introduces Fe3O4@ZIF-8 core–shell nanoparticles that simultaneously provide antibacterial activity and promote bone regeneration for jaw osteomyelitis therapy. By leveraging pH-responsive Zn2+ release and synergistic magnetic field effects, the platform addresses persistent infection and bone defect repair—limitations of current clinical strategies.

• Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-05-14

  Explore the Cy5 TSA Fluorescence System Kit for advanced signal amplification in immunocytochemistry and in situ hybridization. This article uniquely dissects the mechanistic, quantitative, and workflow-driven advantages of HRP-catalyzed tyramide deposition, offering researchers actionable insights beyond standard protocols.

• Cy5-UTP (Cyanine 5-UTP): Advanced RNA Probe Labeling for Tra

  2026-05-14

  Discover how Cy5-UTP (Cyanine 5-uridine triphosphate) revolutionizes in vitro transcription RNA labeling for modern molecular biology, with a deep dive into translational mRNA nanovaccine research and next-generation assay design.

• GLT-1 Upregulation Attenuates TBI via CB1-CREB Pathway Modul

  2026-05-13

  This study demonstrates that enhancing GLT-1 expression in astrocytes can significantly mitigate neuronal apoptosis and cognitive dysfunction after traumatic brain injury by inhibiting the CB1-CREB signaling pathway. The findings elucidate a mechanistic link between cannabinoid signaling, glutamate homeostasis, and neuroprotection, with implications for advancing memory impairment and TBI research.

• Remdesivir (GS-5734): Antiviral Benchmarks and Application L

  2026-05-13

  Remdesivir (GS-5734) is a potent antiviral nucleoside analogue prodrug that targets viral RNA-dependent RNA polymerase. It shows low-nanomolar inhibition of SARS-CoV and MERS-CoV in vitro and complete protection in Ebola virus primate models. This article details verifiable efficacy data, mechanisms, and key workflow considerations for research use.

• Safe DNA Gel Stain: Enhancing Nucleic Acid Visualization & S

  2026-05-12

  Safe DNA Gel Stain from APExBIO revolutionizes DNA and RNA visualization with high sensitivity and reduced mutagenicity, enabling safer, more reproducible results. Its compatibility with blue-light excitation not only preserves DNA integrity but also enhances downstream applications like cloning and sequencing, setting it apart from legacy stains such as ethidium bromide.

• Peroxiredoxin-Induced Autophagy in Macrophages by E. histoly

  2026-05-12

  This study uncovers that peroxiredoxin (Prx) from Entamoeba histolytica induces autophagy in macrophages, primarily via the TLR4–TRIF signaling pathway. The findings provide new insight into host–pathogen interactions and highlight Prx’s role in modulating innate immunity and autophagy-related cell death.

• AM 281 and the CB1-CREB Axis: Strategy for TBI Neuroprotecti

  2026-05-11

  This article explores the mechanistic and translational impact of AM 281, a selective CB1 cannabinoid receptor antagonist, in mitigating cognitive dysfunction and neuronal apoptosis following traumatic brain injury (TBI). Integrating recent evidence on the CB1-CREB-GLT-1 signaling axis, we provide strategic guidance for researchers leveraging AM 281 in neuropharmacology workflows, highlight protocol considerations, and map out the competitive and translational landscape. The discussion extends beyond standard product summaries, connecting molecular insights to actionable strategies for advancing memory impairment research and neurotrauma therapeutics.

• THZ1 as a Covalent CDK7 Inhibitor: Guiding Translational Onc

  2026-05-11

  This article delivers an advanced, evidence-driven perspective on THZ1’s utility as a covalent CDK7 inhibitor in cancer biology, with a particular focus on T-cell acute lymphoblastic leukemia (T-ALL). We dissect the mechanistic basis for its efficacy, synthesize data from in vitro and in vivo studies, and offer strategic guidance for translational researchers seeking to bridge molecular insight with workflow optimization. Building on recent advances in transcription regulation and enhancer biology, this piece situates THZ1 as a next-generation tool for exploring and modulating oncogenic transcriptional programs, while clarifying its differentiation from standard product guides and conventional non-covalent inhibitors.

• IGFBP2-THBS1 Axis: Mechanism of GH-Induced Bone Growth in IS

  2026-05-10

  This study elucidates how recombinant human growth hormone (GH) promotes bone growth in idiopathic short stature (ISS) children via activation of the IGF-1 pathway, specifically through IGFBP2-mediated inhibition of THBS1. The findings clarify a key molecular mechanism in GH therapy, providing a foundation for targeted optimization of ISS treatment.

• CLK2 Drives Platinum Resistance in Ovarian Cancer via BRCA1

  2026-05-09

  This study uncovers Cdc2-like kinase 2 (CLK2) as a critical mediator of platinum resistance in ovarian cancer. By elucidating how CLK2-mediated phosphorylation of BRCA1 enhances DNA repair and reduces cisplatin-induced apoptosis, the research highlights a novel therapeutic target for overcoming chemotherapy resistance.

• Triamcinolone Protocols: Handling Synthetic Glucocorticoid A

  2026-05-09

  Triamcinolone is a synthetic glucocorticoid agonist supplied for research applications involving glucocorticoid signaling, anti-inflammatory mechanisms, and immunosuppression studies. It is not suitable for diagnostic or clinical purposes, and requires precise handling due to its solubility and storage profile.

• Cyclophosphamide: Applied Workflows in Cancer Research Model

  2026-05-08

  Cyclophosphamide from APExBIO sets a benchmark for reproducibility in cancer research and immune modulation, with protocol-driven flexibility spanning apoptosis induction to bone marrow transplantation conditioning. This guide translates recent reference findings and cross-validated workflows into actionable strategies, troubleshooting tips, and comparative insights for advanced bench applications.

• Pentoxifylline: Translational Leverage in Inflammation Resea

  2026-05-07

  This article provides translational researchers with mechanistic insights and strategic guidance on leveraging Pentoxifylline—a non-specific phosphodiesterase inhibitor—for advanced inflammation and immunomodulation studies. By integrating new data on ICAM-1 downregulation in monocytes, outlining protocol parameters, and mapping the clinical-translational bridge, it offers a differentiated, evidence-driven roadmap for maximizing the scientific and workflow value of Pentoxifylline (APExBIO, SKU C3816).

• VER 155008: HSP 70 Inhibitor Workflows for Cancer & Viral Re

  2026-05-07

  VER 155008, an adenosine-derived HSP 70 inhibitor, empowers researchers to interrogate apoptosis and cancer cell proliferation with quantitative precision. Its mechanism-driven workflow integration and direct impact on host-virus interactions set it apart for translational and mechanistic studies.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page